Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) EBT Margin (2018 - 2025)

TransMedics (TMDX) has 8 years of EBT Margin data on record, last reported at 42.35% in Q4 2025.

  • For Q4 2025, EBT Margin fell 1906.0% year-over-year to 42.35%; the TTM value through Dec 2025 reached 1.9%, up 179.0%, while the annual FY2025 figure was 17.56%, 1746.0% up from the prior year.
  • EBT Margin reached 42.35% in Q4 2025 per TMDX's latest filing, down from 13.77% in the prior quarter.
  • Across five years, EBT Margin topped out at 94.71% in Q4 2022 and bottomed at 239.29% in Q3 2021.
  • Average EBT Margin over 5 years is 32.45%, with a median of 14.8% recorded in 2023.
  • Peak YoY movement for EBT Margin: plummeted -16763bps in 2021, then skyrocketed 22556bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 130.85% in 2021, then soared by 172bps to 94.71% in 2022, then plummeted by -60bps to 38.07% in 2023, then plummeted by -161bps to 23.29% in 2024, then tumbled by -82bps to 42.35% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 42.35% in Q4 2025, 13.77% in Q3 2025, and 21.03% in Q2 2025.